Clinical Trial Update: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and cisplatin plus sorafenib in advanced biliary tract cancers (extrahepatic cholangiocarcinoma and gallbladder cancer) has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-03